Cofnodi Dyfyniadau

Citação APA (7ª ed.)
Moon, D., Hur, S., Lee, S., Jeong, M. H., Cho, K. H., Kwon, O., . . . Group, E. P. S. R. (2025). Real-World Safety and Effectiveness of Evolocumab in Korean Patients with Atherosclerotic Cardiovascular Disease or Familial Hypercholesterolemia: A Post-Marketing Surveillance Study. Adis, Springer Healthcare.
Citação do estilo Chicago (17ª ed.)
Moon, Donggyu, Seung-Ho Hur, Sang-Rok Lee, Myung Ho Jeong, Kyung Hoon Cho, Osung Kwon, JinSeon Jeong, Ki Dong Yoo, e Evolocumab Post-Marketing Surveillance Research Group. Real-World Safety and Effectiveness of Evolocumab in Korean Patients with Atherosclerotic Cardiovascular Disease or Familial Hypercholesterolemia: A Post-Marketing Surveillance Study. Adis, Springer Healthcare, 2025.
Citação MLA (9ª ed.)
Moon, Donggyu, et al. Real-World Safety and Effectiveness of Evolocumab in Korean Patients with Atherosclerotic Cardiovascular Disease or Familial Hypercholesterolemia: A Post-Marketing Surveillance Study. Adis, Springer Healthcare, 2025.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.